Cargando…
Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
Bile duct, pancreatic, and gastric cancers are deadly digestive system tumors with high malignancy and poor patient prognosis. The efficiencies of conventional surgical treatment, radiation therapy, and chemotherapy are limited. In contrast, chimeric antigen receptor (CAR) T-cell therapy represents...
Autores principales: | Feng, Qiang, Sun, Baozhen, Xue, Tianyi, Li, Rong, Lin, Chao, Gao, Yongjian, Sun, Liqun, Zhuo, Yue, Wang, Dongxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628995/ https://www.ncbi.nlm.nih.gov/pubmed/36341440 http://dx.doi.org/10.3389/fimmu.2022.1025608 |
Ejemplares similares
-
Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022) -
Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022) -
Advances of hydrogel combined with stem cells in promoting chronic wound healing
por: Li, Qirong, et al.
Publicado: (2022) -
Choledochal Cyst with Carcinoma of the Intrahepatic Bile Ducts and Pancreatic Ducts
por: Dexter, D.
Publicado: (1957) -
The role of RNA modification in hepatocellular carcinoma
por: Feng, Qiang, et al.
Publicado: (2022)